US authorities probing several other drugmakers amid pricing row.
Re-vamped coaching app and remote patient monitoring platform will also debut.
Concerns following event on HAVEN1 trial.
Tafinlar and Mekinist looks set for approval in BRAF V600 lung cancer
Roche rival has Breakthrough Therapy status.
Four in ten EEA doctors considering quitting, says survey.
Company looking to smartwatch and health markets as next step.
Activist investor’s intervention adds to buzz surrounding BMS.